跳至主要内容
临床试验/NCT00545961
NCT00545961Unknown4 期

Clinical Relevance of Middle Meatal Bacteriology During Acute Respiratory Infection in Children - Randomised, Double-Blinded Clinical Study

Oulu University Hospital3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
120
试验地点
3
主要终点
Duration of continuous daily symptoms of the acute respiratory infection diagnosed at the study entry.

研究概览

简要总结

The purpose of this study is to find out whether the children with respiratory infection and the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus benefit from antimicrobial treatment.

详细描述

Acute sinusitis is one of the most common disease in children requiring antimicrobial treatment. The diagnosis and treatment outcomes of acute sinusitis are contradictory, and better diagnostic criteria are needed. In adults with acute maxillary sinusitis, bacterial culture results obtained from the nasal middle meatus are comparable to those obtained from sinus puncture and aspiration. In children, the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus during respiratory infection predicts longer duration of signs and symptoms of common cold.

In this randomized placebo-controlled study, the effect of the antimicrobial treatment (amoxicillin-clavulanate) is examined in children with pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus during respiratory infection. The duration of the symptoms and speed of recovery is recognized by daily symptom-diary, the results are compared between the treatment groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • acute respiratory infection with nasal symptoms (nasal obstruction or discharge)
  • seeking medical help from health centre for the respiratory symptoms
  • pathogenic bacteria (S pneumoniae, H influenzae or M catarrhalis) identified from right or left nasal middle meatus in the endoscopically taken swab culture sampling taken by a study investigator (all microbiological analyses are done by the National Public Health Institute´s microbiological laboratory in Oulu)

排除标准

  • otitis, tonsillitis or other disease requiring antimicrobial treatment
  • respiratory infection within 4 weeks of screening
  • antimicrobial treatment within 4 weeks of screening
  • allergy to penicillin or amoxicillin

研究组 & 干预措施

1

Placebo Comparator

placebo Ora-Plus (registered trademark) mixture with an strawberry sweetening agent to make the placebo mixture similar in appearance and taste to active drug

干预措施: placebo (Drug)

2

Active Comparator

amoxicillin-clavulanate acid

干预措施: amoxicillin clavulanate acid (Drug)

结局指标

主要结局

Duration of continuous daily symptoms of the acute respiratory infection diagnosed at the study entry.

时间窗: within the first 3 weeks after enrolment

次要结局

  • duration (days)and severity (grade mild, severe) of different symptoms (clear nasal discharge, coloured nasal discharge, nasal obstruction, cough, throat pain, ear ache, fever, headache, diarrhea)(within the first three weeks after enrolment)
  • number of days the child is using the following symptomatic drugs (pain killers, nasal vasoconstrictors, nasal corticosteroids, asthma drugs, antihistamines)(within the first three weeks after the enrolment)
  • number of days the child is not at school and that the parents are not at work(within the first three weeks after enrolment)

研究者

申办方类型
Other

研究点 (3)

Loading locations...

相似试验